Related Experiment Video
Updated: Jun 5, 2026

10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Animal models of heart failure recent developments and perspectives
1Division of Cardiology, Department of Medicine, University of California San Diego, School of Medicine, La Jolla, CA 92093-0613, USA.
Trends in Cardiovascular Medicine
|January 18, 2011
Summary
Animal models are crucial for studying heart failure mechanisms and treatments. This review evaluates various models, highlighting their strengths and weaknesses for advancing cardiovascular medicine.
Area of Science:
- Cardiovascular Medicine
- Translational Research
- Animal Models
Background:
- Heart failure is a complex syndrome with diverse causes.
- End-stage heart failure involves cardiac dilation and neurohumoral responses.
- No single animal model perfectly replicates human heart failure pathophysiology.
Purpose of the Study:
- To review advantages and disadvantages of existing heart failure animal models.
- To discuss models for exploring disease mechanisms and interventions.
- To assess suitability for clinical translation.
Main Methods:
- Review of naturally occurring and induced animal models of heart failure.
- Analysis of models in large animals (dog, pig) and small animals (rat, hamster, mouse).
- Focus on models relevant to disease mechanisms and therapeutic strategies.
Main Results:
- Large animal models offer insights but have limitations.
- Small animal models provide accessibility and genetic manipulation potential.
- Gene-based mouse models are emerging for molecular mechanism studies.
Conclusions:
- Diverse animal models are essential for understanding heart failure.
- Model selection depends on the specific research question.
- Advancements in genetic and physiological techniques enhance mouse model utility.
Related Concept Videos
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
